https://www.selleckchem.com/pr....oducts/Clofarabine.h
There was, however, a significant increase in the odds of being transferred to an acute care facility (odds ratio, 4.40 [95% confidence interval CI, 3.40-5.67]) and in acute care costs ($9711 [95% CI, $6961-$12 462]). Our findings of high cost and increased risk of transfer from LTCC to acute care are important because they highlight the substantial clinical and economic impact of MRSA infections in this population. Our findings of high cost and increased risk of transfer from LTCC to acute care are important because they highlight